$EOLS
Evolus, Inc.
$6.74
+0.11
(+1.66%)
Today
A volume-weighted average price line from the last reported earnings date through today.
About Evolus, Inc.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
- CEO
- Mr. David Moatazedi
- Employees
- 350
- Headquarters
- Newport Beach, CA
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Website
- evolus.com
Key stats
- Market Cap
- $443.86M
- P/E Ratio
- —
- Avg Volume (3M)
- 857.14K
- EPS
- $-0.66
- Day's Range
- $6.67 – $7.00
Fundamentals as of Jun 18, 2026